Trust that already ‘punches above its weight’ on digital and health tech will inspire staff with the latest technology and ‘art of the possible’ innovations at the event on 20 July.
The Countess of Chester Hospital NHS Foundation Trust has become the latest organisation to announce that it will host an Elevate health tech showcase to inspire staff at all levels with the latest in technology and digital innovation.
Bristol NHS Group, in partnership with Highland, has successfully hosted its first Local Health Tech Showcase, bringing health and social care staff from across Bristol, North Somerset and South Gloucestershire (BNSSG) together with leading technology suppliers to explore how digital innovation can support frontline services and improve patient care.
Held at BAWA Health & Leisure, the event welcomed more than 250 attendees, who engaged directly with 40 exhibitors, showcasing a wide range of digital and physical solutions designed to address the real-world challenges faced by the NHS and its workforce.
From saving surgeons’ precious time, to reducing surprises and clinical risks in theatre, cutting MDT time in half, and informing decisions before procedures, surgical teams in the SWASH+ consortium of NHS trusts are embracing a ’game changer’ in orthopaedic planning technology with Sectra. David Howard, orthopaedic surgical practitioner at Hampshire Hospitals NHS Foundation Trust, gives the detail.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows.
A new showcase series is reshaping NHS-supplier engagement. Pioneers at the first NHS host brought together hundreds of staff organisation-wide, along with major tech companies and niche innovators in a single day, already inspiring 10 further NHS providers to follow in 2026.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that the PreciseOnco consortium, coordinated by Philips, has been awarded funding from the EU’s Innovative Health Initiative (IHI) to advance precision cancer treatment through the integration of advanced medical imaging, robotic assistance, and minimally invasive therapies.